Trastuzumab Rezetecan Neoadjuvant Therapy in THP-Insensitive HER2-Positive Early Breast Cancer
Clinical trial NCT07647263 · RECRUITING
Trial details
- NCT number
- NCT07647263
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-24
- Primary completion
- 2029-06-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.